Site icon Advocatz

How Safe is the COVID Vaccine? Judicial Watch Sues For Information

We believe that there is no vaccine for any virus or disease that is safe for everyone. All individuals have unique medical issues which may or may not interfere with a vaccine, and therefore the choice of whether or not to get vaccinated must not be mandated.

See this Report:

VIEW LITTLER’S COVID-19 VACCINE EMPLOYER SURVEY REPORT

This report summarizes and analyzes data gathered from more than 1,800 in-house lawyers, HR professionals and C-suite executives. The survey gauged employers’ key concerns, plans and strategies related to COVID-19 vaccination among their workforces.

Disclaimer: The survey questions and their resulting findings cover issues that are governed by various laws and regulations. The content does not convey or constitute legal advice, nor is it intended to be acted upon as such.

Executive Summary

For employers, the new year has brought an urgent question to the fore: Should we mandate COVID-19 vaccinations for our workforce?

The sentiment gathered from more than 1,800 in-house lawyers, HR professionals and C-suite executives across the country who responded to our survey boils down to two words: “Probably not.”

Less than 1 percent currently mandate vaccination for all employees, and only 6 percent say they plan to once vaccinations are readily available and/or the U.S. Food and Drug Administration (FDA) grants full approval. Though that number might go up as time goes on – 43 percent haven’t written off the idea of a mandate completely – 48 percent have already decided that they will not require employees to be vaccinated.

Given the potential legal and administrative issues at play – for instance, exemptions or accommodations for employees with religious objections, pregnant or lactating workers, and those with disabilities that may prevent them from getting vaccinated – it’s unsurprising that 64 percent of respondents expressed concern around legal liability (if employees experience an adverse reaction to the vaccine) and that 57 percent questioned the effectiveness of a mandate given the number of potential exemptions.

But perhaps more surprising is that these issues were not even employers’ top concerns. Those were reserved for cultural quandaries, like pushback from employees who refuse to get the vaccine or oppose it generally (79 percent) and the impact a mandate might have on company culture and employee morale (67 percent). The concern was also widely captured in verbatim responses, many of which noted that a mandate would be perceived as an infringement of basic civil liberties.

Mandate aside, most employers do plan to encourage employees to get the vaccine. Nearly 90 percent said they would provide information to employees (e.g., how to get vaccinated, the benefits of doing so) and nearly 40 percent said they would offer vaccine administration at their facility to increase convenience – even though this may be easier said than done. A third said they would offer paid time off for employees to receive the vaccine and/or recover from any side effects.

Of course, without a mandate, there will inevitably be a split in the workforce between those who have received the vaccine and those who have not. Thus, nearly 75 percent of respondents have some level of concern about providing reasonable on-site accommodations to those who have not been or refuse to get vaccinated. There is also widespread recognition that other policies – involving remote work, testing and more – will play a crucial role in providing safe workplaces.

*********************************

We are huge fans of the work of Tom Fitton and Judicial Watch, so we hope that the Freedom of Information request on COVID vaccination safety described below will give more information to private and public employers on how to balance the health and safety of all employees while protecting the workplace and the general good.

Betsy Combier, Editor
betsy.combier@gmail.com
Editor, ADVOCATZ.com
Editor, ADVOCATZ Blog
Editor, NYC Rubber Room Reporter
Editor, Parentadvocates.org
Editor, New York Court Corruption
Editor, National Public Voice
Editor, NYC Public Voice
Editor, Inside 3020-a Teacher Trials 

Judicial Watch Sues for Records on COVID Vaccine Safety Studies

November 1, 2022

Why is the Biden administration hiding information about the safety of the vaccine it is so aggressively pushing on everyone?

We filed a Freedom of Information Act (FOIA) lawsuit against the U.S. Department of Health and Human Services (HHS) for records on COVID-19 vaccine safety studies (Judicial Watch, Inc. v. U.S. Department of Health and Human Services (No. 1:22-cv-03153)).

We sued in the U.S. District Court for the District of Columbia after the National Institutes of Allergies and Infectious Diseases (a component of HHS) inadequately responded to a June 1, 2022, FOIA request for:

  1. All safety studies, data, reports, and analyses produced by the Division of Microbiology and Infectious Diseases (DMID) relating to the safety of ‘vaccines’ and/or gene therapies to treat and/or prevent SARS-CoV-2 and/or COVID-19 made by Pfizer, BioNTech, Moderna, Johnson & Johnson, and Janssen.
  2. All emails sent to and from the following DMID officials relating to the safety of ‘vaccines’ and/or gene therapies to treat and/or prevent SARSCoV-2 and/or COVID-19 made by Pfizer, BioNTech, Moderna, Johnson & Johnson, and Janssen:
a. The Director of DMID
b. The head of the Office of Genomics & Advanced Technologies
c. The head of the Office of International Research in Infectious Diseases
d. The head of the Office of Regulatory Affairs
e. The head of the Office of Clinical Research Affairs
f. The head of the Clinical Trials Management Section
g. The head of the Virology Branch
h. The head of the Respiratory Diseases Branch
i. The head of the Influenza, SARS, and Other Viral Respiratory Diseases Section

On May 3, 2022, the National Institutes of Health (NIH) released a paper titled “Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine – An Interim Analysis” that “evaluated early safety and immunogenicity after a third mRNA vaccination in adults who received the mRNA-1273 primary series in the Phase 1 trial approximately 9 to 10 months earlier.”

Contributors to that study include three affiliates of the DMID: Mamodikoe Makhene (DMID medical officer), Wendy Buchanan (DMID Clinical Project Manager) and Paul Roberts (DMID Chief Respiratory Pathogens Clinical Research).

The Biden administration is playing shell games with documents on the COVID vaccine. The arrogant cover-up of COVID vaccine safety information further undermines public confidence in these already controversial drugs.

Through previous FOIA activity, we uncovered a substantial amount of information about COVID-19 issues:

Despite all of this work, Judicial Watch is just getting started! I’ll keep you updated as more lawsuits are filed and more information comes in!

Exit mobile version